Skip to main content
Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020
Published Web Location
https://doi.org/10.1038/s41408-022-00750-1Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.